Metastatic, Castration-Resistant

Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Published on 08/07/2025 at 18:03 | prnewswire.co.uk

DelveInsight Business Research, LLP California United States of America United Kingdom


+14699457679
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

 

 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/metastatic-castration-resistant-prostate-cancer-clinical-trial-pipeline-appears-robust-with-90-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-302272435.html

en | boerse | 67993568 |